Walgreens Boots Alliance ... (WBA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company.
It operates through two segments, the United States and International.
The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
It also provides central specialty pharmacy services and mail services.
As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies.
The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application.
It also engages in pharmaceutical wholesaling and distribution business in Germany.
As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis.
Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Country | United States |
IPO Date | Mar 17, 1980 |
Industry | Medical - Pharmaceuticals |
Sector | Healthcare |
Employees | 193,000 |
CEO | Timothy C. Wentworth |
Contact Details
Address: 108 Wilmot Road Deerfield, Illinois United States | |
Website | https://www.walgreensbootsalliance.com |
Stock Details
Ticker Symbol | WBA |
Exchange | NASDAQ |
Fiscal Year | September - August |
Reporting Currency | USD |
CIK Code | 0001618921 |
CUSIP Number | 931427108 |
ISIN Number | US9314271084 |
Employer ID | 47-1758322 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Timothy C. Wentworth | Chief Executive Officer & Director |
Dr. Neal Joseph Sample Ph.D. | Executive Vice President & Chief Information Officer |
Lanesha T. Minnix J.D. | Executive Vice President & Global Chief Legal Officer |
Manmohan Mahajan | Executive Vice President & Global Chief Financial Officer |
Ornella Barra | Chief Operating Officer of International |
Elizabeth L. Burger | Executive Vice President & Chief Human Resources Officer |
Mary Langowski | Executive Vice President & President of U.S Healthcare |
Matthew D'Ambrosio | Senior Vice President and Global Chief Compliance & Ethics Officer |
Stefano Pessina | Executive Chairman of the Board |
Todd D. Heckman | Senior Vice President, Global Controller & Chief Accounting Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 14, 2025 | 13F-HR | Quarterly report filed by institutional managers, ... |
Feb 11, 2025 | 8-K | Current Report |
Feb 10, 2025 | SCHEDULE 13D/A | [Amend] Filing |
Feb 10, 2025 | 4 | Filing |
Feb 07, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 05, 2025 | 8-K | Current Report |
Feb 03, 2025 | 4 | Filing |
Feb 03, 2025 | 4 | Filing |
Feb 03, 2025 | 4 | Filing |
Jan 30, 2025 | 8-K | Current Report |